Shelanski ML - Search Results

1

Synaptic changes in Alzheimer's disease and its models.

Pozueta J, Lefort R, Shelanski ML. Pozueta J, et al. Among authors: shelanski ml. Neuroscience. 2013 Oct 22;251:51-65. doi: 10.1016/j.neuroscience.2012.05.050. Epub 2012 Jun 9. Neuroscience. 2013. PMID: 22687952 Review.

2

Neurogenic effect of beta-amyloid peptide in the development of neural stem cells.

López-Toledano MA, Shelanski ML. López-Toledano MA, et al. Among authors: shelanski ml. J Neurosci. 2004 Jun 9;24(23):5439-44. doi: 10.1523/JNEUROSCI.0974-04.2004. J Neurosci. 2004. PMID: 15190117 Free PMC article.

3

Caspase-2 mediates neuronal cell death induced by beta-amyloid.

Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. Troy CM, et al. Among authors: shelanski ml. J Neurosci. 2000 Feb 15;20(4):1386-92. doi: 10.1523/JNEUROSCI.20-04-01386.2000. J Neurosci. 2000. PMID: 10662829 Free PMC article.

4

Activating transcription factor 4 (ATF4) modulates post-synaptic development and dendritic spine morphology.

Liu J, Pasini S, Shelanski ML, Greene LA. Liu J, et al. Among authors: shelanski ml. Front Cell Neurosci. 2014 Jun 30;8:177. doi: 10.3389/fncel.2014.00177. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25071442 Free PMC article.

5

Cytoskeleton and NGF in the pathogenesis and treatment of Alzheimer's disease.

Shelanski ML. Shelanski ML. Neurobiol Aging. 1989 Sep-Oct;10(5):577; discussion 588-90. doi: 10.1016/0197-4580(89)90134-6. Neurobiol Aging. 1989. PMID: 2812230

6

Activating Transcription Factor 4 (ATF4) Regulates Neuronal Activity by Controlling GABA_BR Trafficking.

Corona C, Pasini S, Liu J, Amar F, Greene LA, Shelanski ML. Corona C, et al. Among authors: shelanski ml. J Neurosci. 2018 Jul 4;38(27):6102-6113. doi: 10.1523/JNEUROSCI.3350-17.2018. Epub 2018 Jun 6. J Neurosci. 2018. PMID: 29875265 Free PMC article.

7

Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ_1-42 synaptotoxicity.

Qu X, Yuan FN, Corona C, Pasini S, Pero ME, Gundersen GG, Shelanski ML, Bartolini F. Qu X, et al. Among authors: shelanski ml. J Cell Biol. 2017 Oct 2;216(10):3161-3178. doi: 10.1083/jcb.201701045. Epub 2017 Sep 6. J Cell Biol. 2017. PMID: 28877993 Free PMC article.

8

Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind).

López-Toledano MA, Shelanski ML. López-Toledano MA, et al. Among authors: shelanski ml. J Alzheimers Dis. 2007 Nov;12(3):229-40. doi: 10.3233/jad-2007-12304. J Alzheimers Dis. 2007. PMID: 18057556

9

Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress.

Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, Greene LA. Park DS, et al. Among authors: shelanski ml. J Neurosci. 1998 Feb 1;18(3):830-40. doi: 10.1523/JNEUROSCI.18-03-00830.1998. J Neurosci. 1998. PMID: 9437005 Free PMC article.

10

Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo.

Troy CM, Brown K, Greene LA, Shelanski ML. Troy CM, et al. Among authors: shelanski ml. Neuroscience. 1990;36(1):217-37. doi: 10.1016/0306-4522(90)90364-a. Neuroscience. 1990. PMID: 2215919 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters